scispace - formally typeset
L

Luc Letenneur

Researcher at University of Bordeaux

Publications -  128
Citations -  19338

Luc Letenneur is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 51, co-authored 123 publications receiving 17440 citations. Previous affiliations of Luc Letenneur include Université Bordeaux Segalen & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Jean-Charles Lambert, +215 more
- 01 Dec 2013 - 
TL;DR: In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10−8) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.
Journal ArticleDOI

Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer’s disease

J-C Lambert, +48 more
- 01 Sep 2009 - 
Journal ArticleDOI

Analysis of shared heritability in common disorders of the brain

Verneri Anttila, +720 more
- 22 Jun 2018 - 
TL;DR: It is demonstrated that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine, and it is shown that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures.
Journal ArticleDOI

Rates and risk factors for dementia and Alzheimer’s disease Results from EURODEM pooled analyses

Lenore J. Launer, +13 more
- 01 Jan 1999 - 
TL;DR: Female gender, current smoking, and low levels of education, and current smoking increased the risk of AD significantly, while head trauma was not a risk factor for AD, and smoking did not protect against AD.
Journal ArticleDOI

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

Sophie Larrieu, +7 more
- 26 Nov 2002 - 
TL;DR: MCI was a good predictor of AD with an annual conversion rate of 8.3% and a good specificity, but it was very unstable over time: Within 2 to 3 years, only 6% of the subjects continued to have MCI, whereas >40% reverted to normal.